Phase IIA Single-Arm Study of Treatment of Patients with Advanced Liver Cancer with a Combination of TATE (Transarterial Tirapazamine Embolization) Followed by an Anti- PD-1 Monoclonal Antibody

UCI-16-94
NCT03259867
Cancer - Colon, Cancer - Liver, Cancer - Rectum
Nadine Abi-Jaoudeh
Open
Treatment
BMS-936558, MDX-1106, Nivolumab, Pembrolizumab, Tirapazamine
II
Adult
Local

For information about cancer clinical trials at the UCI Health Chao Family Comprehensive Cancer Center, call toll-free 877-UC-STUDY (877-827-8839) or email ucstudy@uci.edu.